17-58279553-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PP3_ModeratePP5_ModerateBS2_Supporting
The NM_000250.2(MPO):āc.518A>Gā(p.Tyr173Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000843 in 1,614,076 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ).
Frequency
Genomes: š 0.00050 ( 0 hom., cov: 32)
Exomes š: 0.00088 ( 2 hom. )
Consequence
MPO
NM_000250.2 missense
NM_000250.2 missense
Scores
12
6
1
Clinical Significance
Conservation
PhyloP100: 3.62
Genes affected
MPO (HGNC:7218): (myeloperoxidase) Myeloperoxidase (MPO) is a heme protein synthesized during myeloid differentiation that constitutes the major component of neutrophil azurophilic granules. Produced as a single chain precursor, myeloperoxidase is subsequently cleaved into a light and heavy chain. The mature myeloperoxidase is a tetramer composed of 2 light chains and 2 heavy chains. This enzyme produces hypohalous acids central to the microbicidal activity of neutrophils. [provided by RefSeq, Nov 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.939
PP5
Variant 17-58279553-T-C is Pathogenic according to our data. Variant chr17-58279553-T-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 3627.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr17-58279553-T-C is described in Lovd as [Pathogenic].
BS2
High Homozygotes in GnomAdExome4 at 2 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPO | NM_000250.2 | c.518A>G | p.Tyr173Cys | missense_variant | 4/12 | ENST00000225275.4 | NP_000241.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MPO | ENST00000225275.4 | c.518A>G | p.Tyr173Cys | missense_variant | 4/12 | 1 | NM_000250.2 | ENSP00000225275.3 |
Frequencies
GnomAD3 genomes AF: 0.000499 AC: 76AN: 152182Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
76
AN:
152182
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000458 AC: 115AN: 250860Hom.: 1 AF XY: 0.000472 AC XY: 64AN XY: 135730
GnomAD3 exomes
AF:
AC:
115
AN:
250860
Hom.:
AF XY:
AC XY:
64
AN XY:
135730
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000879 AC: 1285AN: 1461776Hom.: 2 Cov.: 32 AF XY: 0.000854 AC XY: 621AN XY: 727188
GnomAD4 exome
AF:
AC:
1285
AN:
1461776
Hom.:
Cov.:
32
AF XY:
AC XY:
621
AN XY:
727188
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000499 AC: 76AN: 152300Hom.: 0 Cov.: 32 AF XY: 0.000389 AC XY: 29AN XY: 74470
GnomAD4 genome
AF:
AC:
76
AN:
152300
Hom.:
Cov.:
32
AF XY:
AC XY:
29
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
5
ALSPAC
AF:
AC:
4
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
34
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 27, 2022 | Reported as a single heterozygous variant in an individual with complete MPO deficiency who was presumed to have a second undetected variant, and was also identified in the heterozygous state in several of his relatives with partial MPO deficiency (DeLeo et al., 1998); Reported as a heterozygous germline variant in several individuals with myeloid neoplasms (Kongkiatkamon et al., 2022); Published functional studies demonstrate a damaging effect: lack of mature MPO, retention in the endoplasmic reticulum, and significantly reduced MPO activity (DeLeo et al., 1998); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31589614, 36011324, 16183032, 20981092, 27013444, 9637725, 35761024) - |
Pathogenic, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Myeloperoxidase deficiency Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 15, 1998 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D
Eigen
Pathogenic
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at